BIOGEN INC. Operating Income 2007-2022 | BIIB
Beta
What is operating income?
Operating income can be defined as profit from core business operations, calculated as gross profit minus operating expenses, before interest and taxes.
What is BIOGEN INC.'s current operating income?
BIOGEN INC. (BIIB) annual operating income for 2021 was $2.84B, a 37.57% decline from 2020. BIOGEN INC. operating income for the quarter ending March 31, 2022 was $610.7M.
What was BIOGEN INC.'s operating income in 2020?
BIOGEN INC. annual operating income for 2020 was $4.55B, a 35.39% decline from 2019.
What was BIOGEN INC.'s operating income in 2019?
BIOGEN INC. annual operating income for 2019 was $7.04B, a 19.60% increase from 2018.
What is BIOGEN INC.'s 5-year operating income CAGR?
BIOGEN INC. operating income grew at a compound annual growth rate (CAGR) of 11.22% from FY2016 to FY2021, going from $5.15B to $2.84B over 5 years.
Operating Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-11.2%
FY2016
$5.15B
→
FY2021
$2.84B
070809101112131415161718192021
5 years selected
Operating Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2021 | $2.84B | -37.6% | 10-K |
| FY2020 | $4.55B | -35.4% | 10-K |
| FY2019 | $7.04B | +19.6% | 10-K |
| FY2018 | $5.89B | +10.2% | 10-K |
| FY2017 | $5.35B | +3.8% | 10-K |
| FY2016 | $5.15B | +5.3% | 10-K |
| FY2015 | $4.89B | +23.1% | 10-K |
| FY2014 | $3.97B | +57.9% | 10-K |
| FY2013 | $2.52B | +35.5% | 10-K |
| FY2012 | $1.86B | +7.6% | 10-K |
| FY2011 | $1.72B | +38.1% | 10-K |
| FY2010 | $1.25B | -3.6% | 10-K |
| FY2009 | $1.30B | +6.7% | 10-K |
| FY2008 | $1.21B | +55.6% | 10-K |
| FY2007 | $779.8M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →